A class IIa peptide from Enterococcus mundtii inhibits bacteria associated with otitis media

International Journal of Antimicrobial Agents

Volumn 31, Issue 3, 2008, Pages 228-234

  Knoetze, H ^a   Todorov, S D ^a   Dicks, L M T ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

Antibacterial activity; Enterococcus mundtii; Otitis media; Peptide

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; BACTERIAL DNA; BACTERIAL ENZYME; BACTERIAL PROTEIN; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; DEXAMETHASONE PLUS TOBRAMYCIN; FURAZOLIDONE; FUSIDIC ACID; LINCOSAMIDE DERIVATIVE; MACROLIDE; NITROIMIDAZOLE; NOSE SPRAY; OFLOXACIN; PENICILLIN DERIVATIVE; PROTEIN ST4SA; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SOFRADEX; SULFONAMIDE; TETRACYCLINE; TOBRAMYCIN; TRIMETHOPRIM; UNCLASSIFIED DRUG; UNINDEXED DRUG; VANCOMYCIN; VIBROCIL;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ENTEROCOCCUS MUNDTII; GRAM POSITIVE BACTERIUM; MEMBRANE TRANSPORT; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; OTITIS MEDIA; PRIORITY JOURNAL; PROTON MOTIVE FORCE; PROTON TRANSPORT; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BACTERIOLYSIS; DNA, BACTERIAL; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ATOMIC FORCE; OTITIS MEDIA; PEPTIDES; PROTON-MOTIVE FORCE;

EID: 39149137828     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2007.10.010     Document Type: Article

References (34)

1. Segal N., Leibovitz E., Dagan R., and Lieberman A. Acute otitis media-diagnosis and treatment in the era of antibiotic resistant organisms: updated clinical practice guidelines. Int J Pediatr Otorhinolaryngol 69 (2005) 1311-1319
2. McCracken G.H. Diagnosis and management of acute otitis media in the urgent care setting. Ann Emerg Med 39 (2002) 413-421
3. Klein J.O. Management of acute otitis media in an era of increasing antibiotic resistance. Int J Pediatr Otorhinolaryngol 49 Suppl. 1 (1999) S15-S17
4. Cleveland J., Montville T.J., Nes I.F., and Chikindas M.L. Bacteriocins: safe, natural antimicrobials for food preservation. Int J Food Microbiol 71 (2001) 1-20
5. Brook I., and Gober A.E. Bacterial interference in the nasopharynx following antimicrobial therapy of acute otitis media. J Antimicrob Chemother 41 (1998) 489-492
6. Riley M.A., and Wertz J.E. Bacteriocins: evolution, ecology, and application. Annu Rev Microbiol 56 (2002) 117-137
7. Hancock R.E., and Patrzykat A. Clinical development of cationic antimicrobial peptides: from natural to novel antibiotics. Curr Drug Targets Infect Disord 2 (2002) 79-83
8. Ryan M.P., Flynn J., Hill C., Ross R.P., and Meaney W.J. The natural food grade inhibitor, lacticin 3147, reduced the incidence of mastitis after experimental challenge with Streptococcus dysgalactiae in non-lactating dairy cows. J Dairy Sci 82 (1999) 2625-2631
9. Delves-Broughton J., Blackburn P., Evans R.J., and Hugenholtz J. Applications of the bacteriocin, nisin. Antonie Van Leeuwenhoek 69 (1996) 193-202
10. Giacometti A., Cirioni O., Del Prete M.S., Paggi A.M., D'Errico M.M., and Scalise G. Combination studies between polycationic peptides and clinically used antibiotics against Gram-positive and Gram-negative bacteria. Peptides 21 (2000) 1155-1160
11. Ingham A.B., Ford M., Moore R.J., and Tizard M. The bacteriocin piscicolin 126 retains antilisterial activity in vivo. J Antimicrob Chemother 51 (2003) 1365-1371
12. Wachsman M.B., Farias M.E., Takeda E., et al. Antiviral activity of enterocin CRL35 against herpes virus. Int J Antimicrob Agents 12 (1999) 293-299
13. Wachsman M.B., Castilla V., De Ruiz Holgado A.P., et al. Enterocin CRL35 inhibits late stages of HSV-1 and HSV-2 replication in vitro. Antiviral Res 58 (2003) 17-24
14. Knoetze H. Characterization of a broad-spectrum antimicrobial peptide from Enterococcus mundtii active against bacteria associated with middle-ear infections. MSc thesis, University of Stellenbosch, Stellenbosch, South Africa.
15. Sambrook J.E., Eritsch F., and Maniatis J. Molecular cloning: a laboratory manual. 2nd ed. (1989), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
16. Ivanova I., Miteva V., Stefanova T.S., et al. Characterization of a bacteriocin produced by Streptococcus thermophilus 81. Int J Food Microbiol 42 (1998) 147-158
17. Todorov S.D., and Dicks L.M.T. Parameters affecting the adsorption of plantaricin 423, a bacteriocin produced by Lactobacillus plantarum 423 isolated from sorghum beer. J Biotechnol 1 (2006) 405-409
18. Todorov S.D., Powell J.E., Meincken M., Witthuhn R.C., and Dicks L.M.T. Factors affecting the adsorption of Lactobacillus plantarum bacteriocin bacST8KF to Enterococcus faecalis and Listeria innocua. Int J Dairy Technol 60 (2007) 221-227
19. Todorov S.D., Wachsman M.B., Knoetze H., Meincken M., and Dicks L.M.T. An antibacterial and antiviral peptide produced by Enterococcus mundtii ST4V isolated from soya beans. Int J Antimicrob Agents 25 (2005) 508-513
20. Ananou S., Gálvez A., Martýnez-Bueno M., Maqueda M., and Valdivia E. Synergistic effect of enterocin AS-48 in combination with outer membrane permeabilizing treatments against Escherichia coli 0157:H7. J Appl Microbiol 99 (2005) 1364-1372
21. Sparo M.D., Castro M.S., Andino P.J., et al. Partial characterization of enterocin MR99 from a corn silage isolate of Enterococcus faecalis. J Appl Microbiol 100 (2006) 123-134
22. Jennes W., Dicks L.M.T., and Verwoerd D.J. Enterocin 012, a bacteriocin produced by Enterococcus gallinarum isolated from the intestinal tract of ostrich. J Appl Microbiol 88 (2002) 349-357
23. Todorov S.D., and Dicks L.M.T. Lactobacillus plantarum isolated from molasses produces bacteriocins active against Gram-negative bacteria. Enzyme Microb Technol 36 (2005) 318-326
24. Cintas L.M., Casaus P., Herranz C., et al. Biochemical and genetic evidence that Enterococcus faecium L50 produces enterocins L50A and L50B, the sec-dependent enterocin P, and a novel bacteriocin secreted without an N-terminal extension termed enterocin Q. J Bacteriol 182 (2000) 6806-6814
25. Yildrimim Z., Avsar Y.K., and Yildirim M. Factors affecting the adsorption of buchnericin LB, a bacteriocin produced by Lactobacillus buchneri. Microbiol Res 157 (2002) 103-107
26. Manca de Nadra M.C., Sandino de Lamelas D., and Strasser de Saad A.M. Pediocin N5p from Pediococcus pentosaceus: adsorption on bacterial strains. Int J Food Microbiol 39 (1998) 79-85
27. Minahk C.J., Farias M.E., Sesma F., and Morero R.D. Effect of enterocin CRL35 on Listeria monocytogenes cell membrane. FEMS Microbiol Lett 192 (2000) 79-83
28. 2-terminal sequence. Antimicrob Agents Chemother 48 (2004) 2778-2781
29. Kawamoto S., Shima J., Sato R., et al. Biochemical and genetic characterization of mundticin KS, an antilisterial peptide produced by Enterococcus mundtii NFRI 7393. Appl Environ Microbiol 68 (2002) 3830-3840
30. Bennik M.H.J., Vanloo B., Brasseur R., Gorris L.G.M., and Smid E.J. A novel bacteriocin with a YGNGV motif from vegetable-associated Enterococcus mundtii: full characterization and interaction with target organisms. Biochem Biophys Acta 1373 (1998) 47-58
31. Herranz C., Chen Y., Chung H.-J., et al. Enterocin P selectively dissipates the membrane potential of Enterococcus faecium T136. Appl Environ Microbiol 67 (2001) 1689-1692
32. Minahk C.J., Dupuy F., and Morero R.D. Enhancement of antibiotic activity by sub-lethal concentrations of enterocin CRL35. J Antimicrob Chemother 53 (2004) 240-246
33. Low D.E. Mechanisms of antimicrobial resistance. In: Niederman M.S., Sarosi G.A., and Glassroth J. (Eds). Respiratory infections. 2nd ed. (2001), Lippincott Williams and Wilkins, Philadelphia, PA 93-107
34. Gálvez A., Valdivia E., Abriouel H., Camafeita E., Martínez-Bueno E.M.M., and Maqueda M. Isolation and characterization of enterocin EJ97, a bacteriocin produced by Enterococcus faecalis EJ97. Arch Microbiol 171 (1998) 59-65